1. Home
  2. VFC vs GRFS Comparison

VFC vs GRFS Comparison

Compare VFC & GRFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo V.F. Corporation

VFC

V.F. Corporation

HOLD

Current Price

$19.54

Market Cap

6.6B

ML Signal

HOLD

Logo Grifols S.A.

GRFS

Grifols S.A.

HOLD

Current Price

$8.12

Market Cap

5.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VFC
GRFS
Founded
1899
1940
Country
United States
Spain
Employees
N/A
25247
Industry
Apparel
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.6B
5.5B
IPO Year
1994
N/A

Fundamental Metrics

Financial Performance
Metric
VFC
GRFS
Price
$19.54
$8.12
Analyst Decision
Hold
Hold
Analyst Count
18
2
Target Price
$18.24
$10.15
AVG Volume (30 Days)
6.3M
588.1K
Earning Date
05-20-2026
07-28-2022
Dividend Yield
N/A
1.76%
EPS Growth
80.72
N/A
EPS
0.95
N/A
Revenue
$10,488,556,000.00
N/A
Revenue This Year
N/A
$4.49
Revenue Next Year
$2.06
$6.42
P/E Ratio
$20.78
$18.67
Revenue Growth
N/A
N/A
52 Week Low
$11.09
$6.90
52 Week High
$22.27
$11.14

Technical Indicators

Market Signals
Indicator
VFC
GRFS
Relative Strength Index (RSI) 54.44 45.77
Support Level $18.05 $7.52
Resistance Level $20.40 $8.88
Average True Range (ATR) 0.85 0.19
MACD 0.10 -0.02
Stochastic Oscillator 40.73 22.48

Price Performance

Historical Comparison
VFC
GRFS

About VFC V.F. Corporation

VF designs, produces, and distributes branded apparel, footwear, and accessories. Its apparel categories are active, outdoor, and work. Its portfolio of 10 brands includes Vans, The North Face, Timberland, and Altra. VF markets its products in the Americas, Europe, and Asia-Pacific through wholesale sales to retailers, e-commerce, and branded stores owned by the company and partners. Tracing its roots to 1899, the company has evolved through many brand acquisitions and dispositions.

About GRFS Grifols S.A.

Grifols SA one of is global specialty plasma therapeutics companies developing, manufacturing and distributing a broad range of biological medicines based on plasma derived proteins. Plasma derivatives are proteins found in human plasma, which once isolated and purified, have therapeutic value. These protein-based therapies extend and enhance the lives of individuals who suffer from chronic and acute, often life-threatening, conditions, including primary and secondary immunological deficiencies, Chronic Inflammatory Demyelinating Polyneuropathy, immune-mediated ITP. Products and services are used to diagnose and treat patients with hemophilia, immune deficiencies, infectious diseases and a range of other medical conditions. Majority of revenue is from USA.

Share on Social Networks: